Sir Salimullah Medical College Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT03836937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Sir Salimullah Medical College | Sir Salimullah Medical College Mitford Hospital

Active Ingredients

Drugs in Other Trials (2)

lenvatinib (lenvima) (1 trial)

obeticholic acid (ocaliva) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2